Beyond the Liver: Research Links Fatty Liver Disease to Gut Microbiome and Small Intestine Inflammation
For years, fatty liver disease has been viewed primarily as a localized hepatic issue. However, new research is shifting that perspective, suggesting that the root of the problem may actually begin in the gut. A study led by Professor Kim Na-young’s team in the Department of Digestive Internal Medicine has revealed that fatty liver disease is closely linked to inflammation in the small intestine and an imbalance in the gut microbiome.
The findings indicate that the condition is not merely a result of liver dysfunction but is intricately connected to the health of the digestive tract. According to the research conducted by Professor Kim Na-young, the imbalance of intestinal microorganisms and subsequent inflammation in the small intestine play a critical role in the development of the disease.
Dietary habits appear to be a primary trigger for this biological shift. The research highlights that diets high in fructose and fats can lead to a significant decrease in Lactobacillus, a type of beneficial bacteria essential for maintaining gut health. This reduction in healthy bacteria contributes to an environment where inflammation can thrive, eventually impacting the liver. This connection between the small intestine and liver underscores the importance of the gut-liver axis in metabolic health.
Beyond diet, the study addresses a common frustration for many: why some individuals develop fatty liver while others do not, despite eating the same foods. The research suggests that aging is a significant factor, noting that as people get older, the liver tends to accumulate fat more easily even if dietary intake remains constant. This suggests that the body’s ability to manage fats and maintain microbiome balance may decline with age, as noted in reports from health observers.
The discovery that high-fructose and high-fat diets specifically deplete Lactobacillus provides a clearer understanding of how nutrition translates into organ damage. By identifying the small intestine as a potential starting point for liver issues, the research opens new avenues for understanding how to prevent and treat fatty liver disease through gut health management.
These findings underscore a growing consensus in public health: treating metabolic diseases requires a holistic approach. Understanding that the liver is influenced by the gut’s microbial environment could lead to more targeted nutritional interventions and preventative strategies to combat the rising prevalence of fatty liver disease, especially in aging populations, as highlighted by recent reports.
